Europe Tissue Engineering Market Forecast to 2028 – COVID

Europe Tissue Engineering Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Material Type (Synthetic Material, Biologically Derived Materials, and Others) and Application (Orthopedic, Musculoskeletal & Spine, Neurology, Cardiology & Vascular, Skin & Integumentary, Urology, GI & Gynecology, Cancer, and Others)

Report Code : TIPRE00013292 | Region : Europe | Industry : Biotechnology | Published Date : 10/Aug/2022

The tissue engineering market in Europe is expected to grow from US$ 3,859.49 million in 2021 to US$ 8,520.70 million by 2028; it is estimated to grow at a CAGR of 12.0% from 2021 to 2028.

The rising incidence of chronic diseases and increasing number of trauma injuries and road accidents drive the demand for advanced treatment procedures, including tissue engineering. Road accidents are among the major fatalities worldwide as they cause serious injuries to bones and organs. As per the World Health Organization (WHO), ~20–50 million people get injured every year in road accidents. Tissue engineering offers alternatives to surgical reconstruction, transplantation, and mechanical device instruction to repair damaged tissues. The tissue engineering market is mainly driven by a continuous need for effective regenerative treatments to treat increasing cases of diabetes, obesity, and other disorders caused by lifestyle changes; surging population of elderly people; and rising number of trauma cases. A spinal cord injury (SCI) can cause damage to the spinal cord that temporarily or permanently changes its function. Globally, the mean prevalence of traumatic and nontraumatic SCI is estimated at 1:1000, and the annual incidence ranges from 2.1 to 130.7/million in developing countries and from 15 to 39/million in developed countries. According to Multidisciplinary Digital Publishing Institute (MDPI), an estimated 3 million people across the world suffer from traumatic SCI, and ~180,000 new cases are reported each year. SCI often results in devastating, long-lasting neurological deficits, manifesting as dysfunction of the motor, sensory, or autonomic nervous systems below the level of injury. To thoroughly repair or regenerate damaged tissues or organs and restore their functions are required. The advent of Tissue Engineering and Regenerative Medicine (TERM) seems to make this possible. Tissue engineering combines cells, scaffolds, and growth factors to regenerate tissue or replace damaged or diseased tissue. In contrast, regenerative medicine combines tissue engineering with other strategies, including cell-based therapy, gene therapy, and immunomodulation, to induce tissue/organ regeneration in vivo. Cancer is among the leading causes of mortality worldwide, and the disease affects a huge population. Therefore, it acts as a huge financial burden on society. According to the WHO, in 2018, ~9.6 million deaths occurred due to cancer globally. However, growing research on developing effective cancer treatments fuel the market growth. Gene therapy and cell therapy are transforming the cancer treatment landscape. For example, Novartis Kymriah is used in the treatment of diffuse large B-cell lymphoma. The rising number of launches of such products would be drive the demand for cell and gene therapies, which is expected to propel the tissue engineering market in the coming years.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe tissue engineering market at a substantial CAGR during the forecast period.

Europe Tissue Engineering Market Revenue and Forecast to 2028 (US$ Million)

Europe Tissue Engineering Market Segmentation

The Europe tissue engineering market is segmented on the basis of material type, application, and country. Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2021, the biologically derived materials segment held a larger share of the market; and Synthetic Materials is expected to register a higher CAGR during the forecast period. Based on application, the market is categorised into orthopedic, musculoskeletal, & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi, gynecology, urology, and others. In 2021, the orthopedic, musculoskeletal, & spine segment held the largest market share; and skin & integumentary is expected to register the highest CAGR in the market during the forecast period. Based on country, the Europe tissue engineering market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. In 2021, Germany held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.

Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Organogenesis Inc.; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the Europe tissue engineering market.

At 12.0% CAGR, the Europe Tissue Engineering Market is speculated to be worth US$ 8,520.70 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Europe tissue engineering market was valued at US$ 3,859.49 million in 2021 and is expected to reach US$ 8,520.70 million by 2028, registering an annual growth rate of 12.0% from 2021 to 2028. Strengthening technological advancements in the field of 3D tissue engineering and growing number of road accidents and trauma injuries, and elevating incidence of chronic diseases.

3D bioprinting has rapidly transformed the healthcare sector in the last few years. This technology has advanced the development of tissue with clinical potential, paving the way for high-throughput applications for drug discovery. 3D bioprinting tissue-engineering helps in the healing of injuries; new breakthroughs in the 3D printing technique are projected to offer a potential treatment option for organ failure in future. Many research organizations are working toward finding new therapies to treat organ failure and repair cells of damaged tissues. For instance, in 2017, researchers at Penn State University discovered a revolutionary way to print tissues and organs with the use of an “electrospinning printer” that spins fibers seeded with cells to create fiber layers. This technology is both cheaper and offers an opportunity to spin polymer fibers such as collagen layers with precision and in a more controlled manner. In addition to this, scientists at George R. Brown School of Engineering reported the construction of a 3D printed organ that mimics lungs. In April 2019, a researcher at Tel Aviv University printed the world’s first 3D engineered, vascularized heart using a patient’s own cells and biological materials. With advances in stem cell research, intelligent biomaterials, and three-dimensional biofabrication strategies, highly mimicked tissues or organs can be engineered. Future advances in bioprinting include the integration of different printing mechanisms to produce biphasic or triphasic tissues with optimized scaffolds and a further understanding of stem cell biology. More recently, 3D printing has promised tissue manufacturing with micro- to macro-scale structural control through a layer-by-layer approach. Through 3D reconstructions of scanned lesions, bioprinting can precisely deliver cells, growth factors, and biomaterial scaffolds to repair the lesion with different shapes and thicknesses. A promising direction is to combine the bioprinting approaches based on other mechanisms to meet the various challenges. Increasing government funding for research activities is expected to enhance the growth of the tissue engineering market.

On the contrary, expensive cost of treatment options involving tissue engineering.

Based on material type, the Europe tissue engineering market is segment into biologically derived materials, synthetic materials, and others. The biologically derived materials segment held 52.5% market share in 2021, amassing US$ 2,026.57 million. It is projected to garner US$ 4,499.00 million by 2028 to expand at 12.1% CAGR during 2021–2028.

Based on application, the Europe tissue engineering market is segmented into orthopedic, musculoskeletal, & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi, gynecology, urology, and others. The orthopedic, musculoskeletal, & spine segment held 34.4% market share in 2021, amassing US$ 1,327.28 million. It is projected to garner US$ 2,945.24 million by 2028 to expand at 12.1% CAGR during 2021–2028.

Based on country, the Europe tissue engineering market has been segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Our regional analysis states that Germany captured 22.4% market share in 2021. It was assessed at US$ 866.12 million in 2021 and is likely to hit US$ 2,060.52 million by 2028, exhibiting a CAGR of 13.2% during the forecast period.

Key players dominating the Europe tissue engineering market are Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Organogenesis Inc.; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. among others.

In December 2021 Baxter International Inc. had completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing).

In December 2020, Zimmer Biomet Holdings, Inc. announced that the company had completed the acquisition of A&E Medical Corporation, a Vance Street Capital Portfolio Company, for $150 million in cash at closing and $100 million in cash payable in 2021.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Tissue Engineering Market – By Material Type

1.3.2 Europe Tissue Engineering Market – By Application

1.3.3 Europe Tissue Engineering Market – By Country

2. Europe Tissue Engineering Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Tissue Engineering – Market Landscape

4.1 Overview

4.2 Europe

4.3 Expert Opinion

5. Europe Tissue Engineering Market – Industry Dynamics

5.1 Key Drivers

5.1.1 Growing Number of Road Accidents and Trauma Injuries, and Elevating Incidence of Chronic Diseases

5.1.2 Strengthening Technological Advancements in the Field of 3D Tissue Engineering

5.2 Key Market Restraints

5.2.1 Expensive Cost of Treatment Options Involving Tissue Engineering

5.3 Key Market Opportunities

5.3.1 Raising Growth in the Healthcare Market Across the Region

5.4 Future Trends

5.4.1 Burgeoning Advancements in Regenerative Medicine

5.5 Impact Analysis

6. Europe Tissue Engineering Market Analysis

6.1 Europe Tissue Engineering Market Revenue Forecast and Analysis

7. Europe Tissue Engineering Market Analysis – By Material Type

7.1 Overview

7.2 Europe Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

7.3 Synthetic Material

7.3.1 Overview

7.3.2 Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Biologically Derived Materials

7.4.1 Overview

7.4.2 Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Tissue Engineering Market – By Application

8.1 Overview

8.2 Europe Tissue Engineering Market, by Application, 2022 and 2028 (%)

8.3 Orthopedic, Musculoskeletal & Spine

8.3.1 Overview

8.3.2 Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Cardiology & Vascular

8.5.1 Overview

8.5.2 Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Skin & Integumentary

8.6.1 Overview

8.6.2 Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Cancer

8.7.1 Overview

8.7.2 Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.8 GI & Gynaecology

8.8.1 Overview

8.8.2 GI & Gynaecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Urology

8.9.1 Overview

8.9.2 Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Tissue Engineering Market – Country Analysis

9.1 Overview

9.1.1 Europe: Tissue Engineering Market, by Country, 2022 & 2028 (%)

9.1.1.1 Germany: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 Germany: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 Germany Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.3 Germany Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2 UK: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3 UK: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 UK Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 UK Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4 France: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5 France: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1 France Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.2 France Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6 Spain: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1 Spain: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.2 Spain Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.3 Spain Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.7 Italy: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.7.1 Italy: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.7.2 Italy Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.7.3 Italy Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.8 Rest of Europe: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.8.1 Rest of Europe: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.8.2 Rest of Europe Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.8.3 Rest of Europe Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10. Europe Tissue Engineering Market – Industry Landscape

10.1 Organic Developments

10.1.1 Overview

10.2 Inorganic Developments

10.2.1 Overview

11. Company Profiles

11.1 Zimmer Biomet

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 B. Braun Melsungen AG

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Stryker Corporation

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 AbbVie, Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Integra LifeSciences Holdings Corporation

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Organogenesis Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medtronic

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Baxter International Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Johnson and Johnson Services, Inc.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 3M

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

11.11 Cook Biotech Inc.

11.11.1 Key Facts

11.11.2 Business Description

11.11.3 Products and Services

11.11.4 Financial Overview

11.11.5 SWOT Analysis

11.11.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Germany Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             United Kingdom Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             United Kingdom Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             France Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             France Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Spain Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Spain Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Italy Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Italy Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of Europe Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of Europe Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms, Europe Tissue Engineering market

LIST OF FIGURES.

Figure 1.           Europe Tissue Engineering Market Segmentation

Figure 2.           Europe Tissue Engineering Segmentation - By Country

Figure 3.           Europe Tissue Engineering Market Overview

Figure 4.           The Biologically Derived Materials Segment Held Largest Share Of Material Type Segment In Tissue Engineering Market

Figure 5.           Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe Tissue Engineering Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Europe Tissue Engineering Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Europe Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

Figure 10.        Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Tissue Engineering Market, by Application, 2022 and 2028 (%)

Figure 14.        Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        GI & Gynecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe: Tissue Engineering Market, by Key Country – Revenue (2022) (US$ Million)

Figure 23.        Europe: Tissue Engineering Market, by Country, 2022 & 2028 (%)

Figure 24.        Germany: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        UK: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        France: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Spain: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Italy: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Europe: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Europe Tissue Engineering Market

● Zimmer Biomet

● B. Braun Melsungen AG

● Stryker Corporation

● AbbVie, Inc.

● Integra LifeSciences Holdings Corporation      

● Organogenesis Inc.                                                    

● Medtronic

● Baxter International Inc.

● Johnson and Johnson Services, Inc.

● 3M

● Cook Biotech Inc.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Tissue Engineering Market .

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Europe Tissue Engineering Market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Tissue Engineering Market , as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

TOP